NEW YORK (GenomeWeb) – Curetis has received CE-IVD marking for its multiplex PCR-based assay for severe intra-abdominal infections. The firm plans to launch the test at upcoming conferences in Europe.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.